Cargando…

Cost‐effectiveness of multiparametric magnetic resonance imaging and MRI‐guided biopsy in a population‐based prostate cancer screening setting using a micro‐simulation model

BACKGROUND: The introduction of multiparametric magnetic resonance imaging (mpMRI) and MRI‐guided biopsy has improved the diagnosis of prostate cancer. However, it remains uncertain whether it is cost‐effective, especially in a population‐based screening strategy. METHODS: We used a micro‐simulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Getaneh, Abraham M., Heijnsdijk, Eveline AM, de Koning, Harry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209626/ https://www.ncbi.nlm.nih.gov/pubmed/33991077 http://dx.doi.org/10.1002/cam4.3932

Ejemplares similares

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
por: Getaneh, Abraham M., et al.
Publicado: (2020)

Screening for cancers with a good prognosis: The case of testicular germ cell cancer
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2021)

The comparative effectiveness of mpMRI and MRI-guided biopsy vs regular biopsy in a population-based PSA testing: a modeling study
por: Getaneh, Abraham M., et al.
Publicado: (2021)

Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modelled strategies
por: Kregting, Lindy M., et al.
Publicado: (2022)

All‐cause mortality versus cancer‐specific mortality as outcome in cancer screening trials: A review and modeling study
por: Heijnsdijk, Eveline A. M., et al.
Publicado: (2019)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

The potential of breast cancer screening in Europe
por: Zielonke, Nadine, et al.
Publicado: (2020)

Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study)
por: Woo, Henry H., et al.
Publicado: (2022)

Comparison of biopsy under‐sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
por: Li, Weiyu, et al.
Publicado: (2020)

Quantifying the Effect of Location Matching on Accuracy of Multiparametric Magnetic Resonance Imaging Prior to Prostate Biopsy—A Multicentre Study
por: Gavin, Dominic James, et al.
Publicado: (2020)

Cervical cancer screening in a low‐resource setting: a pilot study on an HPV‐based screen‐and‐treat approach
por: Kunckler, Margot, et al.
Publicado: (2017)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014)

Prostate cancer survivors: Risk and mortality in second primary cancers
por: Chattopadhyay, Subhayan, et al.
Publicado: (2018)

Depression and prostate cancer risk: A Mendelian randomization study
por: Chen, Xiong, et al.
Publicado: (2020)

Testicular self-examination and testicular cancer: a cost-utility analysis
por: Aberger, Michael, et al.
Publicado: (2014)

Clinical Utility of Negative Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer and Clinically Significant Prostate Cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021)

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided
por: Rothwax, Jason T., et al.
Publicado: (2014)

AST/ALT ratio as a significant predictor of the incidence risk of prostate cancer
por: Zhou, Jiatong, et al.
Publicado: (2020)

Associations between prostate cancer‐related anxiety and health‐related quality of life
por: Erim, Daniel O., et al.
Publicado: (2020)

Prostate cancer risk in patients with melanoma: A systematic review and meta‐analysis
por: Acharya, Prakash, et al.
Publicado: (2020)

Association between PSA values and surveillance quality after prostate cancer surgery
por: Chapman, Christina Hunter, et al.
Publicado: (2019)

Waist circumference and a body shape index and prostate cancer risk and mortality
por: Jochems, Sylvia H. J., et al.
Publicado: (2021)

External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?
por: Li, Rui, et al.
Publicado: (2021)

Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening
por: Mandrik, Olena, et al.
Publicado: (2019)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers
por: Elamin, Amany, et al.
Publicado: (2015)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Difference in prostate cancer incidence around sixty years: effects of age and metabolic diseases
por: Choi, Jin Bong, et al.
Publicado: (2018)

Body mass index trajectories and prostate cancer risk: Results from the EPICAP study
por: Lavalette, Céline, et al.
Publicado: (2020)

Race, tumor location, and disease progression among low‐risk prostate cancer patients
por: Mygatt, Justin G., et al.
Publicado: (2020)

Estimated annual prevalence, medical service utilization and direct costs of lung cancer in urban China
por: Zhu, Dawei, et al.
Publicado: (2021)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis
por: Hussain, Arif, et al.
Publicado: (2016)

Nonsteroidal anti‐inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP study
por: Doat, Solene, et al.
Publicado: (2017)

Prostate cancer surveillance by occupation and industry: the Canadian Census Health and Environment Cohort (CanCHEC)
por: Sritharan, Jeavana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lpq7db2h2fjqj7e06ipmm9srtk